71 related articles for article (PubMed ID: 24797033)
1. Role of ghrelin hormone in the development of alcohol-associated liver disease.
Mahalingam S; Bellamkonda R; Kharbanda KK; Arumugam MK; Kumar V; Casey CA; Leggio L; Rasineni K
Biomed Pharmacother; 2024 May; 174():116595. PubMed ID: 38640709
[TBL] [Abstract][Full Text] [Related]
2. Antidiabetic features of AdipoAI, a novel AdipoR agonist.
Ahuja A; Zboinski E; das S; Zhu X; Ma Q; Xie Y; Tu Q; Chen J
Cell Biochem Funct; 2024 Jan; 42(1):e3910. PubMed ID: 38269524
[TBL] [Abstract][Full Text] [Related]
3. Decreased AMP-activated protein kinase (AMPK) function and protective effect of metformin in neonatal rat pups exposed to hyperoxia lung injury.
Yadav A; Rana U; Michalkiewicz T; Teng RJ; Konduri GG
Physiol Rep; 2020 Sep; 8(18):e14587. PubMed ID: 32959498
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Abelson Tyrosine-Protein Kinase 2 Suppresses the Development of Alcohol-Associated Liver Disease by Decreasing PPARgamma Expression.
Malnassy G; Keating CR; Gad S; Bridgeman B; Perera A; Hou W; Cotler SJ; Ding X; Choudhry M; Sun Z; Koleske AJ; Qiu W
Cell Mol Gastroenterol Hepatol; 2023; 16(5):685-709. PubMed ID: 37460041
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-inducible gene 6 protein and its derived peptide ameliorate liver fibrosis by repressing CD44 activation in mice with alcohol-related liver disease.
Han J; Lee C; Jeong H; Jeon S; Lee M; Lee H; Choi YH; Jung Y
J Biomed Sci; 2024 May; 31(1):54. PubMed ID: 38790021
[TBL] [Abstract][Full Text] [Related]
6. A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease.
Zhong Z; Lemasters JJ
Alcohol Clin Exp Res; 2018 Nov; 42(11):2072-2089. PubMed ID: 30132924
[TBL] [Abstract][Full Text] [Related]
7. Danshen protects against early-stage alcoholic liver disease in mice via inducing PPARα activation and subsequent 4-HNE degradation.
Ding L; Wo L; Du Z; Tang L; Song Z; Dou X
PLoS One; 2017; 12(10):e0186357. PubMed ID: 29020055
[TBL] [Abstract][Full Text] [Related]
8. Metformin and metabolic diseases: a focus on hepatic aspects.
Zheng J; Woo SL; Hu X; Botchlett R; Chen L; Huo Y; Wu C
Front Med; 2015 Jun; 9(2):173-86. PubMed ID: 25676019
[TBL] [Abstract][Full Text] [Related]
9. Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1.
Bergheim I; Guo L; Davis MA; Lambert JC; Beier JI; Duveau I; Luyendyk JP; Roth RA; Arteel GE
Gastroenterology; 2006 Jun; 130(7):2099-112. PubMed ID: 16762632
[TBL] [Abstract][Full Text] [Related]
10. 24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ.
Grander C; Meyer M; Steinacher D; Claudel T; Hausmann B; Pjevac P; Grabherr F; Oberhuber G; Grander M; Brigo N; Jukic A; Schwärzler J; Weiss G; Adolph TE; Trauner M; Tilg H
JHEP Rep; 2023 Nov; 5(11):100872. PubMed ID: 37818230
[TBL] [Abstract][Full Text] [Related]
11. Metformin treatment prevents experimental metabolic syndrome-induced femoral bone marrow adiposity in rats.
Lasalvia S; Sedlinsky C; Schurman L; McCarthy AD; Wanionok NE
Rev Peru Med Exp Salud Publica; 2024 May; 41(1):28-36. PubMed ID: 38808841
[TBL] [Abstract][Full Text] [Related]
12. Metformin: update on mechanisms of action on liver diseases.
Ruan G; Wu F; Shi D; Sun H; Wang F; Xu C
Front Nutr; 2023; 10():1327814. PubMed ID: 38192642
[TBL] [Abstract][Full Text] [Related]
13. Detection and Quantification of Some Ethanol-Producing Bacterial Strains in the Gut of Mouse Model of Non-Alcoholic Fatty Liver Disease: Role of Metformin.
Abouelkheir M; Taher I; Eladl ASR; Shabaan DA; Soliman MFM; Taha AE
Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242441
[TBL] [Abstract][Full Text] [Related]
14. Ischemic-Trained Monocytes Improve Arteriogenesis in a Mouse Model of Hindlimb Ischemia.
Falero-Diaz G; Barboza CA; Pires F; Fanchin M; Ling J; Zigmond ZM; Griswold AJ; Martinez L; Vazquez-Padron RI; Velazquez OC; Lassance-Soares RM
Arterioscler Thromb Vasc Biol; 2022 Feb; 42(2):175-188. PubMed ID: 34879707
[TBL] [Abstract][Full Text] [Related]
15. Metformin and Probiotics Interplay in Amelioration of Ethanol-Induced Oxidative Stress and Inflammatory Response in an
Patel F; Parwani K; Patel D; Mandal P
Mediators Inflamm; 2021; 2021():6636152. PubMed ID: 33953643
[TBL] [Abstract][Full Text] [Related]
16. Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?
Kim MS; Ong M; Qu X
World J Gastroenterol; 2016 Jan; 22(1):8-23. PubMed ID: 26755857
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance in clinical and experimental alcoholic liver disease.
Carr RM; Correnti J
Ann N Y Acad Sci; 2015 Sep; 1353(1):1-20. PubMed ID: 25998863
[TBL] [Abstract][Full Text] [Related]
18. Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats.
Alwahsh SM; Xu M; Schultze FC; Wilting J; Mihm S; Raddatz D; Ramadori G
PLoS One; 2014; 9(8):e104220. PubMed ID: 25101998
[TBL] [Abstract][Full Text] [Related]
19. Involvement of insulin resistance in the protective effect of metformin against alcoholic liver injury.
Zhu Z; Jiang Z; Zhou J; Zhou D; Wang W; Zhao C; Zhen Z; Nanji AA
Alcohol Clin Exp Res; 2014 Jun; 38(6):1510-9. PubMed ID: 24797033
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
